Meritxell Nus

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial.

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial.

Journal: Nature medicine

Published: December 16, 2024

Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.

Targeting gut microbiota to regulate the adaptive immune response in atherosclerosis.

Journal: Frontiers in cardiovascular medicine

Published: September 26, 2024

T-Cell/B-Cell Interactions in Atherosclerosis.

T-Cell/B-Cell Interactions in Atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: May 30, 2024

Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health.

Damaging mutations in liver X receptor-α are hepatotoxic and implicate cholesterol sensing in liver health.

Journal: Nature metabolism

Published: May 17, 2024

Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities.

Coronavirus disease 2019-related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac magnetic resonance imaging abnormalities.

Journal: Cardiovascular research

Published: March 12, 2024

Immune regulation and blood-brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study - a multicentre prospective cohort study.

Immune regulation and blood-brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study - a multicentre prospective cohort study.

Journal: BMJ open

Published: February 27, 2024

Marginal zone B cells produce 'natural' atheroprotective IgM antibodies in a T cell-dependent manner.

Marginal zone B cells produce 'natural' atheroprotective IgM antibodies in a T cell-dependent manner.

Journal: Cardiovascular research

Published: September 06, 2023

Loss of T follicular regulatory cell-derived IL-1R2 augments germinal center reactions via increased IL-1.

Loss of T follicular regulatory cell-derived IL-1R2 augments germinal center reactions via increased IL-1.

Journal: JCI insight

Published: July 18, 2023

Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis.

Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis.

Journal: Nature

Published: March 11, 2023

Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.

Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis.

Journal: Journal of the American College of Cardiology

Published: August 22, 2022

A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells.

A CRISPR screen targeting PI3K effectors identifies RASA3 as a negative regulator of LFA-1-mediated adhesion in T cells.

Journal: Science signaling

Published: July 20, 2022

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.

Regulatory T-Cell Response to Low-Dose Interleukin-2 in Ischemic Heart Disease.

Journal: NEJM evidence

Published: January 01, 2022

Showing 1-12 of 26

Last Updated: 09/26/2026